Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes.
Saved in:
| Title: | Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes. |
|---|---|
| Authors: | Wong NC; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alvim RG; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shingarev R; Renal Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Power NE; Division of Urology, Western University, London, ON, Canada., Spaliviero M; Stony Brook Medicine, SUNY at Stony Brook, Stony Brook, NY, USA., Murray KS; Department of Surgery, Division of Urology, University of Missouri, Columbia, MO, USA., Benfante NE; Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hakimi AA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Russo P; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Coleman JA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: colemanj@mskcc.org. |
| Source: | European urology focus [Eur Urol Focus] 2019 Nov; Vol. 5 (6), pp. 977-979. Date of Electronic Publication: 2019 Apr 25. |
| Publication Type: | Clinical Trial, Phase III; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
